drugset / Trial / NCT00759551
Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of azilsartan, once daily (QD), in subjects with essential hypertension.
Timeline
- Start
- 2004-08
- Primary completion
- 2005-06
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan | Unknown | 2.5 mg | Oral |
| Subject | Azilsartan | Unknown | 5 mg | Oral |
| Subject | Azilsartan | Unknown | 10 mg | Oral |
| Subject | Azilsartan | Unknown | 20 mg | Oral |
| Subject | Azilsartan | Unknown | 40 mg | Oral |
| Comparator | Olmesartan | Other / unclassified | 20 mg | Oral |